Prime Pharmatech (India) Profile
Key Indicators
- Authorised Capital ₹ 1.75 Cr
- Paid Up Capital ₹ 1.75 Cr
- Company Age 33 Year, 8 Months
- Last Filing with ROC 31 Mar 2020
- Open Charges ₹ 4.19 Cr
- Revenue Growth %
- Net Worth
- Total Assets -53.00%
About Prime Pharmatech (India)
Prime Pharmatech (India) Limited (PPIL) is a Public Limited Indian Non-Government Company incorporated in India on 13 May 1991 and has a history of 33 years and eight months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 1.75 Cr and a paid-up capital of Rs 1.75 Cr.
The company currently has active open charges totaling ₹4.19 Cr.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24239TG1991PLC012702
-
Company No.
012702
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
13 May 1991
-
Date of AGM
31 Dec 2020
-
Date of Balance Sheet
31 Mar 2020
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Prime Pharmatech (India)?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prasant Mahapatra
|
Director | 28-Jan-2017 | Current |
|
Kedar Sharma
|
Additional Director | 19-Feb-2018 | Current |
|
Rajender Rathi
|
Director | 13-May-1991 | Current |
Financial Performance of Prime Pharmatech (India).
Prime Pharmatech (India) Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Prime Pharmatech (India)?
In 2017, Prime Pharmatech (India) had a promoter holding of 18.57% and a public holding of 81.43%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹4.19 Cr
₹0
Charges Breakdown by Lending Institutions
- Canara Bank : 1.40 Cr
- Andhra Pradesh State Financial Corporation : 0.97 Cr
- State Bank Of Hyderabad : 0.90 Cr
- Statebank Of Hyderabad : 0.90 Cr
- Dewam Housing Finance Corporation Ltd. : 0.01 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Jan 2004 | Dewam Housing Finance Corporation Ltd. | ₹0.13 M | Open |
| 10 Sep 1998 | Statebank Of Hyderabad | ₹9.00 M | Open |
| 14 Jun 1996 | Canara Bank | ₹7.00 M | Open |
| 27 May 1995 | Andhra Pradesh State Financial Corporation | ₹3.99 M | Open |
| 07 Oct 1994 | Canara Bank | ₹7.00 M | Open |
How Many Employees Work at Prime Pharmatech (India)?
Unlock and access historical data on people associated with Prime Pharmatech (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Prime Pharmatech (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prime Pharmatech (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
